This has been attributed to increased diagnosis of late-stage breast cancers, which could be explained by delayed diagnosis reflecting the socioeconomic status, cultural beliefs, access to healthcare [1], and the proportion of estrogen receptor (ER)-negative tumors in the Afro-American women [2]. Here, ESR1 is linked to breast carcinoma.